Who are GrafixPL PRIME's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/grafixpl-prime.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

GrafixPL PRIME — Competitive Intelligence Brief

GrafixPL PRIME (GrafixPL PRIME) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Biological wound healing product / Placental tissue allograft. Area: Wound Care / Regenerative Medicine.

marketed Biological wound healing product / Placental tissue allograft Wound Care / Regenerative Medicine Biologic Live · refreshed every 30 min

Target snapshot

GrafixPL PRIME (GrafixPL PRIME) — University of Texas Southwestern Medical Center. GrafixPL PRIME is a placental tissue-derived allograft that provides a biological scaffold and growth factors to promote wound healing and tissue regeneration.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
GrafixPL PRIME TARGET	GrafixPL PRIME	University of Texas Southwestern Medical Center	marketed	Biological wound healing product / Placental tissue allograft

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Biological wound healing product / Placental tissue allograft class)

University of Texas Southwestern Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GrafixPL PRIME — Competitive Intelligence Brief. https://druglandscape.com/ci/grafixpl-prime. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab